Dr Walder Acting Associate Head of School (Research) for the School of Medicine, and is Deputy Head of the Metabolic Research Unit. He is responsible for the day to day activities of the Unit, which consists of approximately 25 full-time research scientists. The MRU conducts research into metabolic diseases, particularly obesity and diabetes, as well as a program in depression and anxiety.
Dr Walders research is primarily focused on the discovery and validation of novel protein targets for metabolic diseases. This research utilises state of the art equipment and technologies, in combination with unique model systems and sample collections, to find novel proteins involved in the development of complex diseases. The novel protein targets are tested in in vitro and in vivo model systems to establish their importance as disease targets.
Awards and prizes
1998 Fogarty Fellowship (NIH)
Memberships
European Association for the Study of Diabetes
American Diabetes Association
Australian Diabetes Society
International Association for the Study of Obesity
North American Association for the Study of Obesity
Australian Society for the Study of Obesity
Service to the University, discipline or community
Dr Walder serves as a reviewer for the following journals:
Diabetes
Diabetologia
International Journal of Obesity
Molecular and General Genetics
Kidney International
Pancreas
Dr Walder regularly reviews research applications for national and international funding bodies, including NHMRC and ARC.
Conferences
1st Scientific Meeting of the Asia-Pacific Diabetes and Obesity Study Group, Kobe, Japan 2005. Invited presentation Genetic variation in PSARL is associated with plasma insulin concentration
American Diabetes Association 65th Scientific Sessions, San Diego, USA 2005. Presentation Functional characterisation of PSARL